Are concerns about reliability in the trial to assess chelation therapy fair grounds for a hasty dismissal?: An alternative perspective

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):5-7. doi: 10.1161/CIRCOUTCOMES.113.000714. Epub 2014 Jan 14.

Author

Affiliation

¹ Division of Cardiology, Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA.

PMID: 24425709
DOI: 10.1161/CIRCOUTCOMES.113.000714

No abstract available

Keywords: Bayes theorem; Editorials.

Publication types

Editorial
Comment

MeSH terms

Chelating Agents / therapeutic use*
Diabetes Complications / complications*
Edetic Acid / therapeutic use*
Female
Humans
Male
Myocardial Infarction / complications*
Myocardial Infarction / prevention & control*

Substances

Chelating Agents
Edetic Acid